Research News and Research

RSS

Massey Cancer Center and VCUarts win Hamilton International Arts in Health Award

Last year, 12 patients in the Supportive Care Clinic at VCU Massey Cancer Center stepped inside a conference room, donned motion sensors and engaged in a facilitated life review, acting out various parts of their lives through a virtual avatar displayed on a projection screen.

30 Oct 2020

Study sheds new light on the biological base of psychotic symptoms

Anti-NMDAR encephalitis is an autoimmune brain illness that is often mistaken by a psychiatric disorder since it causes psychoses and other behaviour alterations. Despite having these similarities, the illness does not respond to common antipsychotic treatments.

30 Oct 2020

Scientists use new approach to analyze millions of chemical-gene interactions

A University of Massachusetts Amherst environmental health scientist has used an unprecedented objective approach to identify which molecular mechanisms in mammals are the most sensitive to chemical exposures.

30 Oct 2020

UC scientist receives research grant to explore the benefits of proprietary surfactants

University of Cincinnati cosmetic scientist Harshita Kumari has received a research grant for more than $700,000 for a multi-year study to explore certain new proprietary surfactants for industrial applications and personal care products such as skin- and haircare as well as laundry detergents.

30 Oct 2020

SARS-CoV-2 load varies widely in the community and over time

A new study published on the preprint server medRxiv* in October 2020 reports that there are large differences in the viral load in different communities. Moreover, the authors say that the cycle threshold values required to obtain a positive result for viral RNA by polymerase chain reaction may provide an early warning of an outbreak.

29 Oct 2020

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

A recent study published in the preprint server bioRxiv in October 2020 describes a reliable animal model to demonstrate the powerful capacity of human neutralizing mAbs directed against SARS-CoV-2 to prevent viral binding the host cell receptor and thus block infection. This indicates the lifesaving value of mAbs in severe COVID-19.

29 Oct 2020

SMART researchers develop novel microcarrier for large-scale cell production

Researchers from Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, have developed a novel microcarrier for large-scale cell production and expansion that offers higher yield and cost-effectiveness compared to traditional methods, and reduces steps required in the cell retrieval process.

29 Oct 2020

New mouth spray could help treat patients with rare genetic skin condition

A new spray for treating severely painful blisters, mouth ulceration and oral scarring in patients with a rare genetic skin condition is being developed by researchers at the University of Birmingham.

29 Oct 2020

Moscow scientists discover and explain the activity mechanism of new anti-cancer molecule

A group of Moscow scientists has discovered and explained the activity mechanism of a new anti-cancer molecule -- diphenylisoxazole.

29 Oct 2020

New machine learning-based approach helps detect atrial fibrillation drivers

Researchers from Skoltech and their US colleagues have designed a new machine learning-based approach for detecting atrial fibrillation drivers, small patches of the heart muscle that are hypothesized to cause this most common type of cardiac arrhythmia.

29 Oct 2020

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

University Hospitals and Case Western Reserve University announced today that UH Cleveland Medical Center has been selected as a clinical trial site for the Phase 3 global study of an investigational vaccine against SARS-CoV-2, sponsored by AstraZeneca.

29 Oct 2020

More intensive, less frequent drug regimen could cure Chagas disease

Researchers in the University of Georgia's Center for Tropical and Emerging Global Diseases have found that a more intensive, less frequent drug regimen with currently available therapeutics could cure the infection that causes Chagas disease, a potentially life-threatening illness affecting up to 300,000 people in the United States.

29 Oct 2020

People with multiple depressive symptoms have higher stroke risk

People with multiple depressive symptoms have an increased risk for stroke, according to findings recently published in Neurology: Clinical Practice.

29 Oct 2020

Researchers identify a novel SARS-CoV-2 variant that spread widely across Europe in summer 2020

Researchers from Basel and Spain have identified a novel SARS-CoV-2 variant that has spread widely across Europe in recent months, according to an un-peer-reviewed preprint released this week.

29 Oct 2020

Toxin-carrying virus implicated in the emergence of new Salmonella strain in pigs

Researchers at the Quadram Institute have implicated a toxin-carrying virus in the emergence of a new strain of Salmonella in pigs.

29 Oct 2020

Study sheds light on the biological base of symptoms in autoimmune psychosis

29 Oct 2020

Mental health challenges associated with COVID-19 lockdown in spring 2020

This brief is a summary of the policy brief prepared in the context of the Swiss national COVID-19 science task force (https://ncs-tf.ch/en/).

29 Oct 2020

Study reveals how gene control mechanisms define the identity of developing brainstem neurons

A recent study at the University of Helsinki reveals how gene control mechanisms define the identity of developing neurons in the brainstem.

29 Oct 2020

Study suggests a role for the hypothalamus in genetic susceptibility to IBD

Using sophisticated 3D genomic mapping and integrating with public data resulting from genome-wide association studies, researchers at Children's Hospital of Philadelphia have found significant genetic correlations between inflammatory bowel disease and stress and depression.

29 Oct 2020

Study finds low risk of adverse events from cardiac MRI contrast agents

Contrast agents used to improve views of the heart on MRI carry a very low risk of allergic reactions, vomiting and other acute adverse events, according to a large study from Europe published in Radiology: Cardiothoracic Imaging.

29 Oct 2020

Research News and Research

Massey Cancer Center and VCUarts win Hamilton International Arts in Health Award

Study sheds new light on the biological base of psychotic symptoms

Scientists use new approach to analyze millions of chemical-gene interactions

UC scientist receives research grant to explore the benefits of proprietary surfactants

SARS-CoV-2 load varies widely in the community and over time

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

SMART researchers develop novel microcarrier for large-scale cell production

New mouth spray could help treat patients with rare genetic skin condition

Moscow scientists discover and explain the activity mechanism of new anti-cancer molecule

New machine learning-based approach helps detect atrial fibrillation drivers

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

More intensive, less frequent drug regimen could cure Chagas disease

People with multiple depressive symptoms have higher stroke risk

Researchers identify a novel SARS-CoV-2 variant that spread widely across Europe in summer 2020

Toxin-carrying virus implicated in the emergence of new Salmonella strain in pigs

Study sheds light on the biological base of symptoms in autoimmune psychosis

Mental health challenges associated with COVID-19 lockdown in spring 2020

Study reveals how gene control mechanisms define the identity of developing brainstem neurons

Study suggests a role for the hypothalamus in genetic susceptibility to IBD

Study finds low risk of adverse events from cardiac MRI contrast agents

A guide to advancing biotherapeutic research eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Event guide: 2nd World RNA-Based Therapeutics & Vaccines Summit Korea

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery